Get the Stockscreener App
0.6833
0.34%
0.0023
After Hours:
.67
-0.0133
-1.95%
Envoy Medical Inc stock is traded at $0.6833, with a volume of 72,596.
It is up +0.34% in the last 24 hours and up +4.35% over the past month.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
See More
Previous Close:
$0.681
Open:
$0.6784
24h Volume:
72,596
Relative Volume:
0.23
Market Cap:
$52.63M
Revenue:
$234.00K
Net Income/Loss:
$-23.11M
P/E Ratio:
-0.6639
EPS:
-1.0292
Net Cash Flow:
$-20.71M
1W Performance:
-9.14%
1M Performance:
+4.35%
6M Performance:
+0.54%
1Y Performance:
-52.55%
1-Day Range:
$0.6784
$0.7299
1-Week Range:
$0.64
$0.8276
52-Week Range:
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
Name
Envoy Medical Inc
Sector
Industry
Phone
651-361-8000
Address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.6833 | 52.63M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | H.C. Wainwright | Buy |
| Jun-24-24 | Initiated | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Stock (COCH) Latest News
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
COCHEnvoy Medical Inc Earnings - Finviz
Envoy Medical, Inc. Warrant 2021-22.04.26 on Envoy Med-A Financial Disclosures & SEC Filings - TradingView
Insiders Of Envoy Medical Are Up 98% On Their US$8.17m Purchase - simplywall.st
Envoy Medical Ends ATM Equity Program Amid Capital Confidence - TipRanks
Envoy Medical Terminates At-The-Market Offering Agreement - TradingView
Envoy Medical (NASDAQ: COCH) terminates $15 million ATM equity facility - Stock Titan
Envoy Medical submits first module of PMA to FDA for implant - Investing.com South Africa
Envoy Medical starts FDA review of its breakthrough hearing device - Stock Titan
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device - TMX Newsfile
COCH Forecast — Price Target — Prediction for 2027 - TradingView
Envoy Medical, Inc. Class A Actuals & Estimates (BOATS:COCH) - TradingView
Envoy Medical boosts CEO Brent Lucas compensation with salary, bonus and equity awards - TradingView
Envoy Medical (NASDAQ: COCH) ties major CEO RSU grant to FDA approval - Stock Titan
Envoy Medical terminates $15 million equity offering facility - Investing.com
COCH: Fully implanted cochlear implant advances toward FDA approval, targeting a vast unmet market - TradingView
Envoy Medical Terminates At-the-Market (ATM) Equity Facility - TMX Newsfile
Envoy Medical terminates $15 million equity offering facility By Investing.com - Investing.com Canada
Envoy Medical shuts down its $15M stock-sale facility - Stock Titan
Form 4 Envoy Medical Inc For: 23 June By Investing.com - Investing.com Nigeria
Envoy Medical (COCH) CEO awarded 1M RSUs plus 1M options tied to FDA OK - Stock Titan
Number of shareholders of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Number of shareholders of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprise of 65% but Stock Declines on Absent RevenueOne-Time Loss Impact - dars.gov.et
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Envoy Medical to Present at Investor Conferences on June 25th - TMX Newsfile
COCH: Innovative fully implanted cochlear implant nears FDA submission, targeting major market disruption - TradingView
Envoy Medical Inc (COCHW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Envoy Medical Inc (COCHW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical Inc (COCHW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Envoy Medical Inc (COCHW) Institutional Confidence - TradingKey
Envoy Medical Inc (COCHW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical Inc (COCHW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Envoy Medical Inc (COCHW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Envoy Medical Inc (COCHW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Inc (COCH) Institutional Confidence - TradingKey
Envoy Medical Inc (COCH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Envoy Medical Inc (COCH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Envoy Medical Inc (COCH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Envoy Medical Inc (COCHW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
[EFFECT] Envoy Medical, Inc. SEC Filing - Stock Titan
COCH Q1 2026 Earnings: Significant EPS Beat Highlights Progress Despite Absence of RevenueForward EPS Estimate - dars.gov.et
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprise Beats Estimates, but Stock Declines Amid Missing RevenueGuidance Upgrade Report - newsline.com
COCH Q1 2026 Earnings: EPS Beat Widens as Pre-Revenue Company Advances DevelopmentPre-Earnings Drift - dars.gov.et
Envoy Medical, Inc. Class A Financial Disclosures & SEC Filings - TradingView
Envoy Medical (COCH) registers 15.12M shares from warrants, $20.1M if cashed - Stock Titan
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - ACCESS Newswire
New to The Street Broadcasting Saturday June 13th 630pm Est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - Moomoo
Envoy Medical Inc Stock (COCH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Envoy Medical Inc Stock (COCH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):